CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)
Generic Name: pancrelipase
Pill imprint CREON 1224 has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease.
Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not subject to the Controlled Substances Act.
See also related documents.
Images for CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)
- Generic Name:
- pancrelipase
- Imprint:
-
CREON 1224
- Strength:
- 120,000 units amylase / 24,000 units lipase / 76,000 units protease
- Color:
- Orange / Clear
- Size:
- 11.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Solvay Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00032-1224
- Inactive Ingredients:
- hypromellose phthalate
polyethylene glycol
triethyl citrate
dimethicone
cetyl alcohol
shellac
soya lecithin
titanium dioxide
gelatin
ferric oxide red
ferric oxide yellow
sodium lauryl sulfate
More resources
Creon is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
